AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,954,023 | +139.3% | 58,403 | +120.9% | 0.00% | – |
Q2 2023 | $1,234,250 | -79.9% | 26,435 | -83.5% | 0.00% | -100.0% |
Q1 2023 | $6,134,303 | -45.6% | 160,332 | -22.1% | 0.00% | -50.0% |
Q4 2022 | $11,282,224 | +8783.6% | 205,880 | +5437.4% | 0.00% | – |
Q3 2022 | $127,000 | +284.8% | 3,718 | +6.2% | 0.00% | – |
Q2 2022 | $33,000 | -96.5% | 3,500 | -94.7% | 0.00% | – |
Q1 2022 | $945,000 | -21.4% | 66,565 | +17.1% | 0.00% | – |
Q4 2021 | $1,203,000 | +24.4% | 56,840 | +31.4% | 0.00% | – |
Q3 2021 | $967,000 | +279.2% | 43,252 | +319.9% | 0.00% | – |
Q2 2021 | $255,000 | -69.3% | 10,301 | -64.0% | 0.00% | – |
Q1 2021 | $830,000 | +422.0% | 28,609 | +364.9% | 0.00% | – |
Q4 2020 | $159,000 | +205.8% | 6,154 | +263.9% | 0.00% | – |
Q3 2020 | $52,000 | +44.4% | 1,691 | +16.5% | 0.00% | – |
Q2 2020 | $36,000 | +71.4% | 1,452 | +43.6% | 0.00% | – |
Q1 2020 | $21,000 | -70.8% | 1,011 | -69.0% | 0.00% | – |
Q4 2019 | $72,000 | -48.2% | 3,261 | -46.6% | 0.00% | – |
Q3 2019 | $139,000 | +561.9% | 6,108 | +446.3% | 0.00% | – |
Q2 2019 | $21,000 | – | 1,118 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |